![Camilla Harder Hartvig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Camilla Harder Hartvig
Directeur/Bestuurslid bij
FLUOGUIDE A/S
Profiel
Camilla Harder Hartvig is currently an Independent Director at Danish Crown A and will be a Director at FluoGuide A starting in 2025.
Formerly, Ms. Hartvig was Chief Commercial Officer & Executive VP at Ascendis Pharma A. The education history includes undergraduate and graduate degrees from Copenhagen Business School.
Actieve functies van Camilla Harder Hartvig
| Bedrijven | Functie | Begin |
|---|---|---|
| FLUOGUIDE A/S | Directeur/Bestuurslid | 24-11-2025 |
Danish Crown A/S
 Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Engages in processing and sale of chilled & frozen meat products, pork, beef, poultry and lamb | Directeur/Bestuurslid | - |
Eerdere bekende functies van Camilla Harder Hartvig
| Bedrijven | Functie | Einde |
|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | - |
Opleiding van Camilla Harder Hartvig
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
21
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Engages in processing and sale of chilled & frozen meat products, pork, beef, poultry and lamb | Consumer Non-Durables |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
FluoGuide A/S
 FluoGuide A/S Pharmaceuticals: MajorHealth Technology Engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent | Health Technology |
